Imagine your skin and your internal organs slowly thickening and hardening, and there’s no cure.
About 100,000 Americans have been diagnosed with systemic sclerosis.
Results from a new drug study are promising for treatment and relief from this rare autoimmune disease of the connective tissue.
The University of Utah is one of nine research hospitals in the U.S. participating in this trial.
Phase three will include a larger group of patients and will probably measure additional outcomes like improved lung function.
Phase three begins within six months.
© 2023 - 910 Media Group